World's Best Scientists 2026 revealed!
Jan T. Kielstein

Jan T. Kielstein

D-Index & Metrics

Medicine

D-Index
79
Citations
20099
World Ranking
17693
National Ranking
925

Overview

Jan T. Kielstein is affiliated with Hannover Medical School in Germany and has an extensive research portfolio primarily in the field of Medicine. Their work spans several subfields including Nephrology, Infectious Diseases, Pulmonary and Respiratory Medicine, Neurology, and Pharmacology.

Their research contributions encompass a range of main topics such as:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Dialysis and Renal Disease Management
  • Antibiotics Pharmacokinetics and Efficacy
  • Mechanical Circulatory Support Devices
  • Long-Term Effects of COVID-19
  • Poisoning and overdose treatments

Kielstein's recent notable publications include:

  • Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection, 2020, Current Hypertension Reports
  • Artificial hallucination: GPT on LSD?, 2023, Critical Care
  • Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease, 2020, European Journal of Internal Medicine
  • Plasma exchange in the intensive care unit: a narrative review, 2022, Intensive Care Medicine
  • Heparin 2.0: A New Approach to the Infection Crisis, 2020, Blood Purification

Frequent co-authors collaborating with Kielstein include:

  • Julius J. Schmidt
  • Gabriele Eden
  • Gernot Beutel
  • Stefan Borgmann
  • Lisa Pilgram

The main journals and venues in which Kielstein regularly publishes are:

  • Nephrology Dialysis Transplantation
  • Journal of the American Society of Nephrology
  • Kidney International
  • Critical Care
  • Clinical Kidney Journal

Overall, Jan T. Kielstein's research emphasizes kidney-related diseases, infectious conditions, and critical care topics, with a particular focus on clinical and pharmacological aspects across multiple interdisciplinary domains.

Best Publications

  • Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

    Jan T. Kielstein;Burcu Impraim;Solveig Simmel;Stefanie M. Bode-Böger

  • Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

    Jan T. Kielstein;Rainer H. Böger;Stefanine M. Bode-Böger;Jürgen Schäffer

  • Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

    Jan T. Kielstein;Rainer H. Böger;Stefanie M. Bode-Böger;Jürgen C. Frölich

  • Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

    Gary R. Matzke;George R. Aronoff;Arthur J. Atkinson;William M. Bennett

  • Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study

    Danilo Fliser;Florian Kronenberg;Jan T. Kielstein;Christian Morath

  • Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study

    Bjoern Becker;Florian Kronenberg;Jan T Kielstein;Hermann Haller

  • Serum uric acid and the risk of cardiovascular and renal disease.

    Claudio Borghi;Enrico Agabiti Rosei;Thomas Bardin;Jesse Dawson

  • Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

    Jan T. Kielstein;Shelley R. Salpeter;Stefanie M. Bode-Boeger;John P. Cooke

  • Symmetrical Dimethylarginine: A New Combined Parameter for Renal Function and Extent of Coronary Artery Disease

    Stefanie M. Bode-Böger;Fortunato Scalera;Jan T. Kielstein;Jens Martens-Lobenhoffer

  • Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study.

    Jan T Kielstein;Ulrich Kretschmer;Thomas Ernst;Carsten Hafer

  • Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

    Jan Menne;Martin Nitschke;Robert Stingele;Mariam Abu-Tair

  • Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension

    Jan T. Kielstein;Stefanie M. Bode-Böger;Gerrit Hesse;Jens Martens-Lobenhoffer

  • Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects

    Jan T. Kielstein;Stefanie M. Bode-Böger;Jürgen C. Frölich;Eberhard Ritz

  • Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

    Jan T. Kielstein;Gernot Beutel;Susanne Fleig;Jürgen Steinhoff

  • ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans

    Jan T. Kielstein;Jan T. Kielstein;Frank Donnerstag;Sandra Gasper;Jan Menne

  • Circulating miR-210 Predicts Survival in Critically Ill Patients with Acute Kidney Injury

    Johan M. Lorenzen;Jan T. Kielstein;Carsten Hafer;Shashi K. Gupta

  • Management of patients at risk of acute kidney injury

    Jill Vanmassenhove;Jan Kielstein;Achim Jörres;Wim Van Biesen

  • Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.

    Claudio Borghi;Enrico Agabiti-Rosei;Richard J. Johnson;Jan T. Kielstein

  • Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?

    Jan T. Kielstein;Carmine Zoccali

  • Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid".

    Jan T. Kielstein;Alexander Woywodt;Shelley R. Salpeter

Frequent Co-Authors

Hermann Haller
Hermann Haller Hannover Medical School
Danilo Fliser
Danilo Fliser Saarland University
Tobias Welte
Tobias Welte University of Hannover
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Alexander Zarbock
Alexander Zarbock University of Münster
Kai-Uwe Eckardt
Kai-Uwe Eckardt Charité - University Medicine Berlin
Thomas Thum
Thomas Thum Hannover Medical School
John P. Cooke
John P. Cooke Houston Methodist
Florian Kronenberg
Florian Kronenberg Innsbruck Medical University
Rinaldo Bellomo
Rinaldo Bellomo Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens many doors beyond the traditional MD route. Online degrees provide flexible, affordable options for those looking to advance quickly and specialize in healthcare fields without putting careers on hold.

For those interested in mental health, the fastest psych np program options allow registered nurses to become psychiatric nurse practitioners in an accelerated format. This caters to urgent workforce needs in behavioral health.

Aspiring healthcare leaders can pursue health administration degrees online, which equip students with management, policy, and organizational skills vital for hospital and clinic administration roles.

Budget-conscious students can benefit from cheap mha programs and the cheapest bsn to dnp programs. These affordable pathways make it possible to earn respected graduate and doctoral credentials online without significant financial burden.

Whether you’re aiming for direct patient care, healthcare management, or advanced nursing practice, these related online degrees provide flexible, accessible pathways for a rewarding medical career in the US.

Best Scientists Citing Jan T. Kielstein

Trending Scientists

Recently Published Articles